Healthy adults
Conditions
Interventions
Daily ingestion of six MSHFS001 tablets before bedtime for 4 weeks.
Daily ingestion of six placebo tablets before bedtime for 4 weeks.
Sponsors
Kao Corporation
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: -Healthy females -Subjects whose Kupperman Kohnenki Shohgai Index (KKSI) are more than medium degree, or below medium degree on a case by case basis. -Subjects who have the symptoms of hot flushes.
Exclusion criteria
Exclusion criteria: -Subjects who have been suffered from disease. -Subjects who regularly take medicine. -Subjects who are undergoing medical treatment or were treated by doctor within a month. -Subjects who are under hormone replacement therapy (HRT), and / or subjects who are in medication that affect blood hormone levels. -Subjects who regularly take supplements related to menopausal symptoms. -Subjects who regularly take functional food and/or supplements related to sleep. -Subjects who are pregnant, lactating, or planned to become pregnant during the test period. -Subjects with smoking habit. -Subjects who cannot follow the restriction of eating habit. -Subjects who have possibilities for emerging allergy to foods, metals, and drugs. -Subjects who are shift workers. -Subjects deemed inappropriate to participate in this study by the principle investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of the 4 weeks ingestion of the development code MSHFS001 on menopausal symptoms and so on. | — |
Countries
Japan
Contacts
Public ContactYuka Enokuchi
Kao Corporation Health Care Food Research
Outcome results
None listed